These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diabetes and obesity: the twin epidemics. Smyth S; Heron A Nat Med; 2006 Jan; 12(1):75-80. PubMed ID: 16397575 [No Abstract] [Full Text] [Related]
24. Looking backwards: a possible new path for drug discovery in psychopharmacology. Shorter E Nat Rev Drug Discov; 2002 Dec; 1(12):1003-6. PubMed ID: 12461521 [TBL] [Abstract][Full Text] [Related]
25. Use of medications for erectile dysfunction in the United States, 1996 through 2001. Wysowski DK; Swann J J Urol; 2003 Mar; 169(3):1040-2. PubMed ID: 12576841 [TBL] [Abstract][Full Text] [Related]
26. Prescribing more psychotropic medications for children: what does the increase mean? Conrad P Arch Pediatr Adolesc Med; 2004 Aug; 158(8):829-30. PubMed ID: 15289260 [No Abstract] [Full Text] [Related]
27. [How many psychotropic drugs does one patient need?]. Steudtner G Z Arztl Fortbild (Jena); 1989; 83(5):267-8. PubMed ID: 2735073 [No Abstract] [Full Text] [Related]
28. A change in the market--investing in diagnostics. Batchelder K; Miller P Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131 [No Abstract] [Full Text] [Related]
29. Using drug samples can hinder quality. Healthcare Benchmarks Qual Improv; 2004 Mar; 11(3):34-5. PubMed ID: 15002360 [TBL] [Abstract][Full Text] [Related]
30. Interest in sex waning? Wyllie MG BJU Int; 2009 Sep; 104(5):719-20. PubMed ID: 19689578 [No Abstract] [Full Text] [Related]
31. [Erectile dysfunction]. Frick J Wien Med Wochenschr; 2000; 150(1-2):1. PubMed ID: 10746285 [No Abstract] [Full Text] [Related]
32. Opportunities and challenges for the development of pharmacological therapies for obesity treatment. Cawthorne MA Obes Rev; 2007 Mar; 8 Suppl 1():131-6. PubMed ID: 17316316 [No Abstract] [Full Text] [Related]
33. Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction. Waack KE; Ernst ME; Graber MA Ann Pharmacother; 2004 Dec; 38(12):2029-34. PubMed ID: 15507499 [TBL] [Abstract][Full Text] [Related]
34. Hunter-gatherers win profit-sharing deal for obesity drug. Wise J Bull World Health Organ; 2003; 81(5):382. PubMed ID: 12856057 [No Abstract] [Full Text] [Related]
35. Value networks identify innovation in 21st century pharmaceutical research. Edwards PJ Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823 [TBL] [Abstract][Full Text] [Related]
37. Surviving the blockbuster syndrome. Service RF Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490 [No Abstract] [Full Text] [Related]
38. Inter-Nordic variations in sales of medicines. Granat M Scand J Soc Med Suppl; 1984; 34():21-4. PubMed ID: 6147012 [No Abstract] [Full Text] [Related]
39. The blockbuster drugs of 1998. Ricchini W Adv Nurse Pract; 1998 Dec; 6(12):35-8, 92. PubMed ID: 9934010 [No Abstract] [Full Text] [Related]
40. Deals landscape: notable deals in the pharmaceutical industry in the second quarter of 2008. Bright J; Lakeram M IDrugs; 2008 Aug; 11(8):584-91. PubMed ID: 18724496 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]